Back to Journals » International Journal of Women's Health » Volume 16

Survival Status and Predictors Among Women with Advanced Stage of Cervical Cancer [Letter]

Authors Wiryanti W, Fikri E

Received 26 April 2024

Accepted for publication 11 May 2024

Published 14 May 2024 Volume 2024:16 Pages 829—830

DOI https://doi.org/10.2147/IJWH.S475715

Checked for plagiarism Yes

Editor who approved publication: Professor Elie Al-Chaer



Wiwin Wiryanti,1 Elanda Fikri2

1Medical Laboratory Technology, Poltekkes Kemenkes Bandung, Bandung, Indonesia; 2Department of Environmental Health, Poltekkes Kemenkes Bandung, Bandung, Indonesia

Correspondence: Wiwin Wiryanti, Medical Laboratory Technology, Poltekkes Kemenkes Bandung, Jl.Babakan Loa, No. 10A, Cimahi, Jawa Barat, Bandung, 40514, Indonesia, Email [email protected]


View the original paper by Ms Teshome and colleagues


Dear editor

We have read a research article entitled Survival Status and Predictors Among Women with Advanced Stage of Cervical Cancer” by Teshome,1 recently published in International Journal of Women’s Health. We congratulate the authors on this successful article and make some contributions. There are four strengths of this study: 1) Focus of this study was on assessing the survival status of advanced cervical cancer patients after starting treatment in Ethiopia, 2) This study makes an important contribution in understanding the factors that influence the survival of cervical cancer patients in resource-limited countries. In addition, 3) This study utilized a prospective cohort study design, which may provide more accurate and relevant data to assist in planning more effective interventions and treatments for advanced cervical cancer patients.

However, we have also discovered several limitations that need to be corrected in the future, namely: 1) This study has limitations in that the follow-up period is limited to only one year, so it does not allow further comparison or discussion of patient survival rates after one year, 2) Some participants in this cohort study did not receive or complete cancer treatment, so should be excluded from the analysis of overall survival rate and median survival time, 3) This study does not have a cancer registry in Ethiopia, so the available data may be limited and incomplete, 4) There is potential bias in data collection and analysis due to limited resources and infrastructure in countries with limited resources such as Ethiopia, 5) This study did not include socioeconomic factors that may influence cervical cancer patient survival, such as healthcare accessibility, social status, or social support.

To obtain better results, we recommend that further research be carried out by 1) Conduct follow-up studies with longer follow-up periods to understand the long-term survival of advanced cervical cancer patients, 2) Expand the scope of the study to include socioeconomic factors that may affect survival, such as healthcare accessibility, income, and social support,2 3) Conduct comparative studies between different methods of treatment of advanced cervical cancer to evaluate the effectiveness and efficiency of each method,3 4) Develop intervention programs aimed at improving early detection of cervical cancer and access to quality healthcare for populations in resource-limited countries.

In conclusion, this study makes a significant contribution to understanding the factors that influence the survival of advanced cervical cancer patients in Ethiopia, by highlighting the importance of early detection, timely treatment, and attention to risk factors such as age and the presence of anemia.

Disclosure

The authors report no conflicts of interest in this communication.

References

1. Teshome R, Yang I, Woldetsadik E, Girma E, Higgins M, Wells J. Survival status and predictors among women with advanced stage of cervical cancer. Int J Womens Health. 2024;16:605–617. doi:10.2147/IJWH.S455235

2. Allanson ER, Schmeler KM. Cervical cancer prevention in low- and middle-income countries. Clin Obstet Gynecol. 2021;64(3):501–518. doi:10.1097/GRF.0000000000000629

3. Sun Y, Li G, Hai P, et al. The comparative study for survival outcome of locally advanced cervical cancer treated by neoadjuvant arterial interventional chemotherapy or intravenous chemotherapy followed by surgery or concurrent chemoradiation. World J Surg Oncol. 2022;20(1):389. doi:10.1186/s12957-022-02859-w

Creative Commons License © 2024 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.